NFIB and neoplasm: STR studies have highlighted that approximately 50% of these tumours (n = 14) demonstrate LOH at 16q, the locus of CYLD18, making the recent finding that 55% of tumours in a similar sized study (n = 12) demonstrate MYB–NFIB fusions of interest 6.